JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:1587-1592, doi:10.1016/j.jacc.2004.06.072
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ezekowitz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ezekowitz, J.

RENAL INSUFFICIENCY AND HEART FAILURE

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

Justin Ezekowitz, MB, BCh, MSc*, Finlay A. McAlister, MD, MSc{dagger},*, Karin H. Humphries, MBA, DSc{ddagger}, Colleen M. Norris, PhD§, Marcello Tonelli, MD, MSc||, William A. Ghali, MD, MPH, Merril L. Knudtson, MD# APPROACH Investigators

* Division of Cardiology, University of Alberta, Edmonton, Canada
{dagger} Division of General Internal Medicine, University of Alberta, Edmonton, Canada
|| Division of Nephrology, University of Alberta, Edmonton, Canada
{ddagger} Division of Cardiology, University of British Columbia, Vancouver, Canada
§ Faculty of Nursing, University of Alberta, Edmonton, Canada
Division of General Internal Medicine, University of Calgary, Calgary, Canada
# Division of Cardiology, University of Calgary, Calgary, Canada

Manuscript received March 1, 2004; revised manuscript received June 15, 2004, accepted June 22, 2004.

* Reprint requests and correspondence: Dr. Finlay A. McAlister, 2E3.24 WMC, University of Alberta Hospital, 8440 112th Street, Edmonton, Alberta, Canada T6G 2R7 (Email: Finlay.McAlister{at}ualberta.ca).

OBJECTIVES: This study was designed to examine the use of cardiovascular medications and outcomes in patients with heart failure (HF) and renal dysfunction.

BACKGROUND: Renal insufficiency is associated with poorer outcomes in patients with HF, but the mechanisms are uncertain. In particular, the degree of therapeutic nihilism in these patients, and whether it is appropriate, is unclear.

METHODS: This was a prospective cohort study with a one-year follow-up.

RESULTS: In 6,427 patients with cardiologist-diagnosed HF and angiographically proven coronary artery disease (mean age 69 years; 65% men; one-year mortality, 10%), 39% had creatinine clearances <60 ml/min. Patients with renal insufficiency were less likely to be prescribed angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, statins, or aspirin (all p < 0.001). However, users of aspirin (odds ratio [OR] 0.69, 95% confidence interval [CI] 0.57 to 0.85), statins (OR 0.79, 95% CI 0.64 to 0.97), and beta-blockers (OR 0.75, 95% CI 0.62 to 0.90) were less likely to die in the subsequent 12 months than nonusers, irrespective of renal function (all OR adjusted for covariates including atherosclerotic burden and ejection fraction). Although ACE inhibitor users with creatinine clearances ≥60 ml/min had lower 12-month mortality (OR 0.72, 95% CI 0.48 to 0.99), ACE inhibitor users with clearances <60 ml/min did not (OR 1.21, 95% CI 0.97 to 1.51).

CONCLUSIONS: Renal insufficiency is common in patients with HF and coronary artery disease, and these patients have more advanced coronary atherosclerosis. Patients with renal insufficiency are less likely to be prescribed efficacious therapies, but have better outcomes if they receive these medications.

Abbreviations and Acronyms
  ACE = angiotensin-converting enzyme
  CAD = coronary artery disease
  CI = confidence interval
  HF = heart failure
  LV = left ventricular
  OR = odds ratio




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
W. A. K. M. Windt, R. H. Henning, A. C. A. Kluppel, Y. Xu, D. de Zeeuw, and R. P. E. van Dokkum
Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats
Nephrol. Dial. Transplant., June 4, 2008; (2008) gfn233v2.
[Abstract] [Full Text] [PDF]


Home page
American Journal of Medical QualityHome page
M. B. Patwardhan, D. B. Matchar, G. P. Samsa, and W. E. Haley
Opportunities for Improving Management of Advanced Chronic Kidney Disease
American Journal of Medical Quality, June 1, 2008; 23(3): 184 - 192.
[Abstract] [PDF]


Home page
CirculationHome page
M. Tonelli, F. Sacks, M. Arnold, L. Moye, B. Davis, M. Pfeffer, and for the Cholesterol and Recurrent Events (CARE) Tr
Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease
Circulation, January 15, 2008; 117(2): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, et al.
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Eur. Heart J., October 1, 2007; 28(19): 2375 - 2414.
[Full Text] [PDF]


Home page
BMJHome page
D. T Eurich, F. A McAlister, D. F Blackburn, S. R Majumdar, R. T Tsuyuki, J. Varney, and J. A Johnson
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
BMJ, September 8, 2007; 335(7618): 497 - 497.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. B. Chonchol, V. Aboyans, P. Lacroix, G. Smits, T. Berl, and M. Laskar
Long-term outcomes after coronary artery bypass grafting: Preoperative kidney function is prognostic
J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 683 - 689.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. G. Glynn, D. Reddan, J. Newell, J. Hinde, B. Buckley, and A. W. Murphy
Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2586 - 2594.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C. C Lang and D. M Mancini
Non-cardiac comorbidities in chronic heart failure
Heart, June 1, 2007; 93(6): 665 - 671.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
F. A. McAlister, A. Oreopoulos, C. M. Norris, M. M. Graham, R. T. Tsuyuki, M. Knudtson, W. A. Ghali, and for the Alberta Provincial Project for Outcome Ass
Exploring the Treatment-Risk Paradox in Coronary Disease
Arch Intern Med, May 28, 2007; 167(10): 1019 - 1025.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. A.K.M. Windt, W. B.A. Eijkelkamp, R. H. Henning, A. C.A. Kluppel, P. A. de Graeff, H. L. Hillege, S. Schafer, D. de Zeeuw, and R. P.E. van Dokkum
Renal Damage after Myocardial Infarction Is Prevented by Renin-Angiotensin-Aldosterone-System Intervention
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3059 - 3066.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
N. I. Parikh, S.-J. Hwang, M. G. Larson, J. B. Meigs, D. Levy, and C. S. Fox
Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
Arch Intern Med, September 25, 2006; 166(17): 1884 - 1891.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. G. Coca, H. M. Krumholz, A. X. Garg, and C. R. Parikh
Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.
JAMA, September 20, 2006; 296(11): 1377 - 1384.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A. X. Garg
Chronic Kidney Disease and Mortality Risk: A Systematic Review
J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2034 - 2047.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. A. McAlister, W. A. Ghali, Y. Gong, J. Fang, P. W. Armstrong, and J. V. Tu
Aspirin Use and Outcomes in a Community-Based Cohort of 7352 Patients Discharged After First Hospitalization for Heart Failure
Circulation, June 6, 2006; 113(22): 2572 - 2578.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. L. Smith, J. H. Lichtman, M. B. Bracken, M. G. Shlipak, C. O. Phillips, P. DiCapua, and H. M. Krumholz
Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis
J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1987 - 1996.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Segura, J. A. Garcia-Donaire, M. Praga, and L. M. Ruilope
Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients
J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S136 - S140.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Tonelli, A. Keech, J. Shepherd, F. Sacks, A. Tonkin, C. Packard, M. Pfeffer, J. Simes, C. Isles, C. Furberg, et al.
Effect of Pravastatin in People with Diabetes and Chronic Kidney Disease
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3748 - 3754.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. T. Eurich, S. R. Majumdar, F. A. McAlister, R. T. Tsuyuki, and J. A. Johnson
Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure
Diabetes Care, October 1, 2005; 28(10): 2345 - 2351.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Tonelli, C. Isles, T. Craven, A. Tonkin, M. A. Pfeffer, J. Shepherd, F. M. Sacks, C. Furberg, S. M. Cobbe, J. Simes, et al.
Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease
Circulation, July 12, 2005; 112(2): 171 - 178.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. D.J. Smilde, H. L. Hillege, D. J. van Veldhuisen, and G. Navis
Angiotensin-Converting Enzyme Inhibitors and Outcome Among Patients With Heart Failure and Renal Insufficiency: Need for a Prospective Study
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1905 - 1905.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J.-P. Bassand, S. Priori, and M. Tendera
Evidence-based vs. 'impressionist' medicine: how best to implement guidelines
Eur. Heart J., June 2, 2005; 26(12): 1155 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Which Drug Therapies Prevent Death in Patients with CAD, Heart Failure, and Renal Insufficiency?
Journal Watch Cardiology, December 3, 2004; 2004(1203): 3 - 3.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.